Floatz logo

176 assets in HER2 Positive Breast Carcinoma

Therapeutic assets addressing HER2 Positive Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
bi-1607
HER2 Positive Breast Carcinoma
BioInvent International ABP1/2CC (41)
Dual-Target Car-Nk Cells
HER2 Positive Breast Carcinoma
Beijing BiotechP1/2CC (41)
sbt6050
HER2 Positive Breast Carcinoma
Silverback TherapeuticsP1/2CC (41)
Axitinib
HER2 Positive Breast Carcinoma
Lynkcell EuropeP1CC (40)
[68Ga]Ga-ABY-025
HER2 Positive Breast Carcinoma
Vanderbilt-Ingram Cancer CenterEarly P1C (39)
Amcenestrant
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP2C (39)
CD47/SIRPA-BLOCKING AGENT ALX148
HER2 Positive Breast Carcinoma
QuantumLeap Healthcare CollaborativeP1C (37)
Elvn-002
HER2 Positive Breast Carcinoma
Enliven TherapeuticsP1C (37)
her2bbζ/cd19t+ t cells
HER2 Positive Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP1C (37)
her2 vaccine
HER2 Positive Breast Carcinoma
Pravin T.P KaumayaP1C (37)
Mvf-Her-2 (266-296)
HER2 Positive Breast Carcinoma
Pravin T.P KaumayaP1C (37)
Orm-5029
HER2 Positive Breast Carcinoma
Orum Therapeutics USA, Inc.P1C (37)
Pepinemab
HER2 Positive Breast Carcinoma
H. Lee Moffitt Cancer Center and Research InstituteP1C (37)
Xmt-2056
HER2 Positive Breast Carcinoma
Day One Biopharmaceuticals, Inc.P1C (37)
Avelumab
HER2 Positive Breast Carcinoma
Royal Marsden NHS Foundation TrustP1C (36)
Iohexol
HER2 Positive Breast Carcinoma
Alison StopeckEarly P1C (34)
Trastuzumab Emtansine For
HER2 Positive Breast Carcinoma
Tianjin Medical University Cancer Institute and HospitalN/AD (30)
Herombopag
HER2 Positive Breast Carcinoma
Zhenzhen LiuN/AD (28)
Eribulin Mesilate
HER2 Positive Breast Carcinoma
MedSIRP1/2NR ()
gq1001
HER2 Positive Breast Carcinoma
Fudan UniversityP1/2NR ()
hlx319
HER2 Positive Breast Carcinoma
Shanghai Henlius BiotechP1NR ()
Patuzumab
HER2 Positive Breast Carcinoma
Henan Cancer HospitalP3NR ()
Shr-A1811 For
HER2 Positive Breast Carcinoma
Jiangsu HengRui Medicine Co., Ltd.P3NR ()
Thero2-01S22
HER2 Positive Breast Carcinoma
Institut de cancérologie Strasbourg EuropeP3NR ()
Showing 151 to 176 of 176 assets
PreviousPage 4 of 4Next